Related references
Note: Only part of the references are listed.Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis
Pablo J. Fernandez-Marcos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury
Marta A. Paiva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Retrograde heart perfusion: The Langendorff technique of isolated heart perfusion
Robert M. Bell et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Does long-term metformin treatment increase cardiac lipoprotein lipase?
David Hauton
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1 alpha or PGC-1 beta and mitofusin 2 in skeletal muscle in type 2 diabetes
Antonio Zorzano et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Transitory Activation of AMPK at Reperfusion Protects the Ischaemic-Reperfused Rat Myocardium Against Infarction
Marta A. Paiva et al.
CARDIOVASCULAR DRUGS AND THERAPY (2010)
Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case-Control Study From the UK General Practice Research Database
Michael R. MacDonald et al.
DIABETES CARE (2010)
Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α) and Sirtuin 1 (SIRT1) Reside in Mitochondria POSSIBLE DIRECT FUNCTION IN MITOCHONDRIAL BIOGENESIS
Katia Aquilano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling
Mostafa M. Elgebaly et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
An energetic tale of AMPK-independent effects of metformin
Russell A. Miller et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
PGC-1 alpha in aging and anti-aging interventions
Rozalyn Anderson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
One Hour Reperfusion is Enough to Assess Function and Infarct Size With TTC Staining in Langendorff Rat Model
R. Ferrera et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure
Susheel Gundewar et al.
CIRCULATION RESEARCH (2009)
Mitochondrial Dynamics in Mammalian Health and Disease
Marc Liesa et al.
PHYSIOLOGICAL REVIEWS (2009)
Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response
Rozalyn M. Anderson et al.
AGING CELL (2008)
Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration
Lasse Solskov et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Transcriptional control of mitochondrial biogenesis:: the central role of PGC-1α
Renee Ventura-Clapier et al.
CARDIOVASCULAR RESEARCH (2008)
Metformin therapy and clinical uses
John H. B. Scarpello et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening
Gurpreet S. Bhamra et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
Aging and cardioprotection
Arshad Jahangir et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-α/PGC-1α gene regulatory pathway
Jennifer G. Duncan et al.
CIRCULATION (2007)
Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis
Richard M. Reznick et al.
CELL METABOLISM (2007)
PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?
M. M. Mocanu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
Masataka Suwa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
PGC-1α:: a key regulator of energy metabolism
Huiyun Liang et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2006)
Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-γ coactivator-1α, estrogen-related receptor-α, and mitofusin 2
Francesc X. Soriano et al.
DIABETES (2006)
Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone
RE Teresi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Diabetes and cardiovascular disease:: The road to cardioprotection
P Monteiro et al.
HEART (2005)
Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle -: Effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor α, and interleukin-6
D Bach et al.
DIABETES (2005)
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment - A potential role for phosphatase and tensin homolog deleted on chromosome ten?
K Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Animal models of diabetes mellitus
DA Rees et al.
DIABETIC MEDICINE (2005)
Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles
M Suwa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:: Potential role of PGC1 and NRF1
ME Patti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Mechanism by which metformin reduces glucose production in type 2 diabetes
RS Hundal et al.
DIABETES (2000)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
Metformin improves vascular function in insulin-resistant rats
PVG Katakam et al.
HYPERTENSION (2000)
Share Paper
